Stay updated on Carfilzomib Combo for Myeloma Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib Combo for Myeloma Clinical Trial page.

Latest updates to the Carfilzomib Combo for Myeloma Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing the previous v3.0.1 tag; the 'Back to Top' element was removed.SummaryDifference0.2%
- Check12 days agoChange DetectedThe web page has been updated to include information on Multiple myeloma under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.4%
- Check19 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to plasma cell myeloma and various chemical compounds. Notably, daratumumab has been added while previous mentions of multiple myeloma and certain medications have been removed.SummaryDifference5%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Carfilzomib Combo for Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib Combo for Myeloma Clinical Trial page.